Pharma Industry News

Merck KGaA puts devices to work against diabetes in Blue Mesa digital program

Written by David Miller

​​​​​​​The latest entrant into the digital diabetes arena is Merck KGaA. The Glucophage maker has teamed with digital healthcare provider Blue Mesa Health to target people recently diagnosed with prediabetes and help prevent their advancing to Type 2.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]